A clinical trial to compare the safety and efficacy of transdermal fentanyl patch and oral ketrolac for pain management in dry socket patients.
- Conditions
- Health Condition 1: PCS- Health Condition 2: R52- Pain, unspecified
- Registration Number
- CTRI/2020/02/023538
- Lead Sponsor
- Department Oral health sciences centre
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1.Patients in the age group between 18- 60 years.
2.Patients who will return to the clinic with symptoms and signs of dry socket, including moderate to severe pain with a VAS score >4, will be included in this study.
3.Good physical and mental condition (ASA I ,II )
4.Absence of infection or trauma.
5.Patients in which Zinc Oxide Eugenol (ZNOE) dressing is given.
6.Patients who can understand English and Hindi Languages.
1.A history of allergy to the drugs used in the present study.
2.All pregnant and lactating females.
3.Alcohol or narcotics abusers.
4.Patients with ulcerative lesions or malignant lesions.
5.Patients who are taking monoamineoxidase inhibitor drugs.
6.Patients who are taking drugs for migraines.
7.Patients who are taking anti-retroviral, antifungal drugs.
8.Patient who have acute (sudden) or severe asthma.
9.Patient who has a gastrointestinal problem called paralytic ileus.
10. Heart or respiratory failure
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.PAIN SCORES IN DRY SOCKET <br/ ><br>Timepoint: 7 DAYS
- Secondary Outcome Measures
Name Time Method 1.SAFETY AND TOLERABILITY OF DRUGS. <br/ ><br>2.NUMBER OF RESCUE MEDICATION TABLETS TAKENTimepoint: 7 DAYS